secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001847903-22-000118
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.04
LLM model:  deepseek-v4-flash:cloud@v2

Centessa obtains waiver for subsidiary name-change default on Note Purchase Agreement
--------------------------------------------------------------------------------

- On Dec 22, 2022, Centessa entered a waiver with lenders for an Event of Default under the Oct 1, 2021 Note Purchase Agreement.
- Default triggered by failure to provide prior written notice of a subsidiary's legal name change on Nov 22, 2022.
- Waiver from Three Peaks Capital Solutions Aggregator Fund and Cocoon SA LLC (Oberland Capital affiliate) avoids loan acceleration and penalties.
- Without waiver, lenders could have accelerated the loan under the Note Purchase Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000118/0001847903-22-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000118/cnta-20221122.htm
  HTML page:      https://secwatch.observer/filing/0001847903-22-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer